Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
BACKGROUND: It is well known that the global population is aging and that those over the age of 80 are the fastest growing part of this expansion. Also known is that prevalence of hypertension and cognitive decline both increase with increasing age. METHOD: The Hypertension in the Very Elderly Trial...
Hlavní autoři: | Peters, R, Beckett, N, Forette, F, Tuomilehto, J, Ritchie, C, Walton, I, Waldman, A, Clarke, R, Poulter, R, Fletcher, A, Bulpitt, C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2009
|
Podobné jednotky
-
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
Autor: Peters, R, a další
Vydáno: (2008) -
Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
Autor: Thijs Lutgarde, a další
Vydáno: (2006-12-01) -
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
Autor: Ruth Peters, a další
Vydáno: (2010-07-01) -
Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
Autor: Michael Okorie, a další
Vydáno: (2019-11-01) -
HYVET Study results: importance for clinical practice
Autor: S. V. Nedogoda
Vydáno: (2008-10-01)